On CNBC’s “The Final Call,” Carter Worth said he liked biotech. He named SPDR S&P Biotech ETF (ARCA: XBI) hit a low on May 11 but “the S&P hasn’t bottomed yet.” “It’s up 32% since then,” he added.
Scott Nations said, “I want to use options to make money while defending my risk even if ExxonMobil Corp. (NYSE: NYSE:XOM) goes nowhere at all.”
Check out other stocks making moves in the premarket.
Also Read: As Credit Suisse (SIX:CSGN)'s Credit Default Swaps Spike To Near 2008 Levels, Rumors Of Lehman-Like Collapse Floated, Bank Steps In To Allay Concerns
Mike Khouw said that he liked call spread risk reversals in SPDR S&P Biotech ETF. “For those of you who are thinking of trying to catch those falling knives, calls are a better way to play it.”
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.